Paralos Bioscience Inc. — Form D/A
Paralos Bioscience Inc. of LOS ANGELES, CA, a company, filed a Form D amendment with the SEC on 2025-09-24. The offering totals $1.0M, of which $150K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-09-24
- Form: D/A
- Accession: 0002080259-25-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $150K
- Remaining: $850K
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2025-07-28
- Security types: equity, debt
- Revenue range: $1 - $1,000,000
- SEC file number: 021-554029
Issuer
- Name: Paralos Bioscience Inc.
- CIK: 0002080259
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: 570 WESTWOOD PLAZA LAB ROOM 6350 ATTN: PARALOS BIOSCIENCE INC (MAGNIFY), LOS ANGELES, CA, 90095
- Phone: 6177108741
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Irene Chen | Director | Newport Beach, CA |
| Irene Chen | Executive Officer | Newport Beach, CA |
| Yanxi Yang | Executive Officer | Los Angeles, CA |
| Irene Chen | Related Person | Newport Beach, CA |
| Yanxi Yang | Related Person | Los Angeles, CA |
Other filings by this issuer (3)
More